Simon Heeke
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities(2021)886 cited
- → Structure-based classification predicts drug response in EGFR-mutant NSCLC(2021)427 cited
- → Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions(2023)320 cited
- → Afatinib for the Treatment of NSCLC Harboring Uncommon EGFR Mutations: A Database of 693 Cases(2020)271 cited
- → Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?(2019)193 cited
- → Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment(2019)140 cited
- → Tumor mutational burden assessment as a predictive biomarker for immunotherapy in lung cancer patients: getting ready for prime-time or not?(2018)107 cited
- → Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity(2022)102 cited
- → Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes(2024)98 cited
- → CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance(2023)97 cited